Amber Johns

Amber Johns is currently the Manager of Product Translation and Data Privacy Officer at Concr, a techbio company focused on predicting patient outcomes for cancer therapies. Amber also holds the position of Honorary Scientist and Program Manager at Garvan Institute of Medical Research, directing the Australian Pancreatic Cancer Genome Initiative. Additionally, Amber serves as Project Developer at ICGC ARGO, working towards analyzing specimens from cancer patients. Previously, Amber was the Director of Patient Partnered Research at VCCC Alliance and Chief Scientist of Histopathology at Laverty Pathology. Amber graduated with a Bachelor of Medical Science from Charles Sturt University.